Pretreatment hemoglobin and response to erythropoietin in CAPD patients
Patrikarea, A.; Pierratos, A.; Mustata, S.; Oreopoulos, D.G.
Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis 15(2): 174-176
1995
ISSN/ISBN: 0896-8608 PMID: 7612741 Document Number: 444425
Document emailed within 1 workday
Related Documents
Lee, S.K.; Park, M.S.; Han, D.C.; Hwang, S.D.; Moon, C.; Lee, H.B. 1992: Effects of erythropoietin-induced hemopoiesis on peritoneal transport and on in vitro T cell response in CAPD Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 8: 453-456Satirapoj, B.; Supasyndh, O.; Choovichian, P. 2014: A comparative study of efficacy and safety of the lyophilized powder alpha-erythropoietin and the liquid form alpha-erythropoietin for hemoglobin maintenance in patients with hemodialysis treatment Journal of the Medical Association of Thailand 97(9): 899-906
Gadducci, A.; Cosio, S.; Fanucchi, A.; Tanganelli, L.; Conte, P.F.; Cristofani, R.; Genazzani, A.R. 2003: Is pretreatment hemoglobin level a predictor of complete response to salvage chemotherapy for recurrent platinum-pretreated ovarian carcinoma? European Journal of Gynaecological Oncology 24(5): 405-410
Ramello, A.; Malcangi, U.; Bruno, M.; Perosa, P.; Reina, E.; Rizzuto, A.; Nasini, M.G.; Carozzi, S. 1990: Treatment of anaemia in CAPD patients with recombinant human erythropoietin Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 6: 308-311
Auer, J.; Simon, G.; Stevens, J.; Griffiths, P.; Howarth, D.; Anastassiades, E.; Gokal, R.; Oliver, D. 1992: Quality of life improvements in CAPD patients treated with subcutaneously administered erythropoietin for anemia Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 12(1): 40-42
Tanabe, R. 1994: Numerical and functional alterations in T and B lymphocyte subpopulations in CAPD patients treated with recombinant human erythropoietin Nihon Jinzo Gakkai Shi 36(10): 1159-1168
Díez, J.J.; Sastre, J.; Iglesias, P.; Selgas, R.; Romero, J.R.; Méndez, J.; Gómez-Pan, A. 1992: Growth hormone responses to pituitary and hypothalamic stimuli in CAPD patients treated with recombinant human erythropoietin Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 8: 340-345
Selgas, R.; Castro, M.J.; Bajo, M.A.; Fernandez-Reyes, M.J.; Lopez-Revuelta, K.; Romero, J.R.; de Alvaro, F.; Borrego, F.; Riñon, C. 1992: Staphylococcus aureus nasal carrier status (SANCS) in CAPD patients; is it induced or favored by subcutaneous rHu-erythropoietin? Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 8: 253-257
Tokgöz, B.; Utaş, C.; Dogukan, A.; Güven, M.; Taşkapan, H.; Oymak, O.; Keleştimur, F. 2001: Effects of long-term erythropoietin therapy on the hypothalamo-pituitary-testicular axis in male CAPD patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(5): 448-454
Paritpokee, N.; Wiwanitkit, V.; Bhokaisawan, N.; Boonchalermvichian, C.; Preechakas, P. 2002: Serum Erythropoietin Levels in Pediatric Patients with ß-Thalassemia/Hemoglobin E Clinical Laboratory 48(11-12): 631-634
Boelaert, J.R.; Schurgers, M.L.; Matthys, E.G.; Belpaire, F.M.; Daneels, R.F.; De Cre, M.J.; Bogaert, M.G. 1989: Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 9(2): 95-98
Vogeser, M.; Schiel, X. 2002: Serum Erythropoietin Concentrations in Patients with Anemia - Preliminary Hemoglobin-Related Reference Ranges Clinical Laboratory 48(11-12): 595-598
Giordano, C.; De Santo, N.G.; Carella, C.; Mioli, V.; Bazzato, G.; Amato, G.; Di Leo, V.A.; Tarchini, G.; Coli, U.; Capodicasa, G. 1984: TSH response to TRH in hemodialysis and CAPD patients International Journal of Artificial Organs 7(1): 7-10
Luo, Y.-H.; Li, Z.-D.; Liu, L.-X.; Dong, G.-H. 2009: Pretreatment with erythropoietin reduces hepatic ischemia-reperfusion injury Hepatobiliary and Pancreatic Diseases International: Hbpd Int 8(3): 294-299
Faggiano, P.; Rusconi, C. 1991: Hemodynamic response to high-dose nitroglycerin infusion in patients with severe heart failure after pretreatment and clinical stabilization Giornale Italiano di Cardiologia 21(11): 1195-1202
Lastiri, Jé.M.; Specterman, S.R.; Rendo, P.; Pallotta, Mía.G.; Varela, M.S.; Goldstein, Sía. 2002: Predictive response variables to recombinant human erythropoietin treatment in patients with anemia and cancer Medicina 62(1): 41-47
Beguin, Y. 2002: Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients Haematologica 87(11): 1209-1221
Rungpitarangsi, B.; Noytong, S.; Fucharoen, S.; Aswapokee, N.; Aswapokee, P.; Komolpit, P.; Tanphaichitr, V.; Rungpitarangsi, V. 1987: Antibody response in beta-thalassemia/Hb e disease, hemoglobin H patients, and nonthalassemics with enteric fever Birth Defects Original Article Series 23(5a): 527-533
Hsu, P-Yaur.; Lin, C-Liang.; Yu, C-Chen.; Chien, C-Chun.; Hsiau, T-Gu.; Sun, T-Hui.; Huang, L-Mei.; Yang, C-Wei. 2004: Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study Journal of Nephrology 17(5): 693-700
Awadzi, K.; Hero, M.; Opoku, N.O.; Büttner, D.W.; Coventry, P.A.; Prime, M.A.; Orme, M.L.; Edwards, G. 1994: The chemotherapy of onchocerciasis XVII. A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics Tropical Medicine and Parasitology: Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft für Technische Zusammenarbeit 45(3): 203-208